Clinical experiences with microwave thermal ablation of lung malignancies

References

• American Cancer Society. Key statistics for lung cancer. 2016. Available from http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-key-statistics (accessed 23 February 2016).
   Google Scholar
• Mazzone P. Preoperative evaluation of the lung resection candidate. Cleveland Clin J Med 2012;79:eS17–22.
   PubMedGoogle Scholar
• Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: A meta-analysis. Int J Radiat Oncol 2014;90:603–11.
   PubMed Web of Science ®Google Scholar
• Jain SK, Dupuy DE, Cardarelli GA, Zheng Z, DiPetrillo TA. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. Am J Roentgenol 2003;181:711–15.
   PubMed Web of Science ®Google Scholar
• Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006;17:1117–24.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith WW. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738–45.
   PubMed Web of Science ®Google Scholar
• McTaggart RA, Dupuy DE, Dipetrillo T. Image guided ablation in the thorax. In: Geschwind JF H, Soulen MC, eds. Interventional oncology: Principles and practice. New York: Cambridge University Press, 2008, pp. 440–74.
   Google Scholar
• Ward RC, Healey TT, Dupuy DE. Microwave ablation devices for interventional oncology. Expert Rev Med Devices 2013;10:225–38.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: Treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology 2009;251:933–40.
   PubMed Web of Science ®Google Scholar
• Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park, NY). 2005;19(11Suppl4):12–21.
   PubMedGoogle Scholar
• Leung VA, DiPetrillo TA, Dupuy DE. Image-guided tumor ablation for the treatment of recurrent non-small cell lung cancer within the radiation field. Eur J Radiol 2011;80:e491–9.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax 1. Radiographics 2002;22:S259–S69.
   PubMed Web of Science ®Google Scholar
• Dupuy DE. Image-guided thermal ablation of lung malignancies. Radiology 2011;260:633–55.
   PubMed Web of Science ®Google Scholar
• Alexander ES, Healey TT, Martin DW, Dupuy DE. Use of endobronchial valves for the treatment of bronchopleural fistulas after thermal ablation of lung neoplasms. J Vasc Interv Radiol 2012;23:1236–40.
   PubMed Web of Science ®Google Scholar
• Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol 2011;79:343–6.
   PubMed Web of Science ®Google Scholar
• vanSonnenberg E, Shankar S, Morrison PR, Nair RT, Silverman SG, Jaklitsch MT, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience – technical and multidisciplinary considerations in 30 patients. Am J Roentgenol 2005;4:381–90.
   Web of Science ®Google Scholar
• Solomon SB, Thornton RH, Dupuy DE, Downey RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol 2008;19:610–15.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Nakamura K, Matsuoka T, Toyoshima M, Okuma T, Oyama Y, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. Am J Roentgenol 2005;185:1299–306.
   PubMed Web of Science ®Google Scholar
• Baeère TD, Palussière J, Aupérin A, Hakime A, Abdel-Rehim M, Kind M, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation 1. Radiology 2006;240:587–96.
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation – what should you use and why? Radiographics 2014;34:1344–62.
   PubMed Web of Science ®Google Scholar
• Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 2010;254:301–7.
   PubMed Web of Science ®Google Scholar
• Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation – preliminary results. Radiology 2003;229:821–9.
   PubMed Web of Science ®Google Scholar
• Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: Effectiveness, CT findings, and safety in 50 patients. Radiology 2008;247:871–9.
   PubMed Web of Science ®Google Scholar
• Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: Imaging features of the postablation zone. Radiographics 2012;32:947–69.
   PubMed Web of Science ®Google Scholar
• Chheang S, Abtin F, Guteirrez A, Genshaft S, Suh R. Imaging features following thermal ablation of lung malignancies. Semin Intervent Radiol 2013;30:157–68.
   PubMed Web of Science ®Google Scholar
• Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2006;20:115–21.
   PubMed Web of Science ®Google Scholar
• Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M, Takeda K. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15:463–70.
   PubMed Web of Science ®Google Scholar
• Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010;211:68–72.
   PubMed Web of Science ®Google Scholar
• de Baere T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015;26:987–91.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015;121:3491–8.
   PubMed Web of Science ®Google Scholar
• Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST J 2013;143:eS278–313.
   Web of Science ®Google Scholar
• Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities – part I. J Vasc Interv Radiol 2001;12:1021–32.
   PubMed Web of Science ®Google Scholar
• Nemcek AA. Complications of radiofrequency ablation of neoplasms. Semin Interv Radiol 2006;23:177–87.
   PubMedGoogle Scholar
• Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT Jr. Pulmonary thermal ablation: Comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 2009;251:705–11.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: Increased lesion diameter with a perfusion electrode. Acad Radiol 1996;3:636–44.
   PubMed Web of Science ®Google Scholar
• Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue – is microwave not just for popcorn anymore? Radiology 2009;251:617–18.
   PubMed Web of Science ®Google Scholar
• Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications 1. Radiographics 2005;25:S69–S83.
   PubMed Web of Science ®Google Scholar
• Belfiore G, Ronza F, Belfiore MP, Serao N, di Ronza G, Grassi R, Rotondo A. Patients’ survival in lung malignancies treated by microwave ablation: Our experience on 56 patients. Eur J Radiol 2013;82:177–81.
   PubMed Web of Science ®Google Scholar
• Palussiere J, Lagarde P, Aupérin A, Deschamps F, Chomy F, de Baere T. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: Results of eight years’ experience in 87 patients from two centers. Cardiovasc Intervent Radiol 2015;38:160–6.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: Clinical utility in treatment of pulmonary metastases. Radiology 2011;261:643–51.
   PubMed Web of Science ®Google Scholar
• Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: Initial experience with more than 200 procedures. Radiology 2005;235:289–98.
   PubMed Web of Science ®Google Scholar
• Maiwand MO. The role of cryosurgery in palliation of tracheo-bronchial carcinoma. Eur J Cardiothorac Surg 1999;15:764–8.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Shulman M. Current status of thermal ablation treatments for lung malignancies. Semin Intervent Radiol. 2010;27:268–75.
   PubMedGoogle Scholar
• Yashiro H, Nakatsuka S, Inoue M, Kawamura M, Tsukada N, Asakura K, et al. Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Intervent Radiol 2013;24:813–21.
   PubMed Web of Science ®Google Scholar
• Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol 2015;26:312–19.
   PubMed Web of Science ®Google Scholar
• De Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, et al. Evaluating cryoablation of metastatic lung tumors in patients – safety and efficacy the ECLIPSE trial – interim analysis at 1 year. J Thorac Oncol 2015;10:1468–74.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070–6.
   PubMed Web of Science ®Google Scholar
• Kwan SW, Mortell KE, Talenfeld AD, Brunner MC. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Intervent Radiol 2014;25:1–9.
   PubMed Web of Science ®Google Scholar
• Kwan SW, Mortell KE, Hippe DS, Brunner MC. An economic analysis of sublobar resection versus thermal ablation for early-stage non–small-cell lung cancer. J Vasc Intervent Radiol 2014;25:1558–64.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, et al. Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621–8.
   PubMed Web of Science ®Google Scholar
• Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, Wain JC, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:160–6.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Gobara H, Mimura H, Matsui Y, Toyooka S, Kanazawa S. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2011;142:24–30.
   PubMed Web of Science ®Google Scholar
• Horkan C, Dalal K, Coderre JA, Kiger JL, Dupuy DE, Signoretti S, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005;235:81–8.
   PubMed Web of Science ®Google Scholar
• Chan MD, Dupuy DE, Mayo-Smith WW, Ng T, DiPetrillo TA. Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small cell lung cancer. Brachytherapy 2011;10:253–9.
   PubMed Web of Science ®Google Scholar